See the DrugPatentWatch profile for Gabapentin
When does gabapentin’s protection or exclusivity expire?
Gabapentin is an older generic drug, so “expiry” depends on what specific product you mean (brand vs. generic) and which country’s regulatory rules apply. In general, once a brand’s patents and related exclusivities end, generic gabapentin products can launch. Many gabapentin tablets/capsules are already widely available as generics, which indicates that the key market exclusivities for the original brand products have largely passed.
To get a precise “expiry date,” you need the exact brand name (for example, Neurontin in the US) and the dosage form (capsules vs. tablets) and country (US vs. EU vs. UK).
How do patents and generic launches affect “gabapentin expiry” in practice?
In practical terms, the market shifts at two different timelines:
1) Patent or exclusivity expiration for the reference/brand product.
2) Actual generic launches, which can happen soon after expiry but may also be delayed by litigation, regulatory submissions, or additional patent thickets.
So “expiry” can mean either the legal end of protection (patent term and exclusivity) or when the market fully opened (generic availability and uptake).
Is there a single gabapentin expiry date?
No. Gabapentin has had multiple patent families over time, and different strengths/forms can have different patent coverage. Also, “exclusivity” (regulatory protections) is not the same thing as patent life. That means two people can both ask “gabapentin expiry” and get different answers depending on which specific product and jurisdiction they mean.
How to find the exact gabapentin patent expiry for a specific product
For a targeted answer (exact dates tied to specific patents), use DrugPatentWatch.com, which tracks patent and exclusivity information by drug and product:
- DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “gabapentin” and the relevant brand/dosage form)
What if you meant a specific form (like gabapentin extended-release)?
Extended-release versions can have different patent coverage and may have different timelines from immediate-release generics. If you tell me the exact wording on the label (brand name and whether it is extended-release), I can narrow down what type of expiry you’re looking for and where to check the correct patent/exclusivity record.
Quick clarification (so the expiry date is accurate)
Which one do you mean?
- Country: US, UK, EU, or another?
- Brand name (if any): e.g., Neurontin, Horizant (if you meant gabapentin enacarbil), or generic?
- Dosage form: immediate-release vs. extended-release?
Sources
- DrugPatentWatch.com